Scientists Just Unlocked an Endless Army of Cancer-Fighting Cells
Scientists at USC have developed a technique to create an endless supply of cancer-fighting immune cells by enabling progenitor cells to self-renew.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers at USC have unlocked a method to generate a continuous supply of cancer-fighting cells. This breakthrough involves progenitor cells that can self-renew in a laboratory setting.
Coverage from Tech Times emphasizes that this development breaks the supply barrier for macrophage therapy. Other reporting from ScienceDaily, ScienceAlert, Tech Explorist, and ThePrint highlights the creation of an "army" of cells designed to combat cancer.
Future developments depend on the application of this new technique to maintain the production of these immune cells for therapy.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
Who is responsible for this discovery?
The discovery was made by scientists at USC.
What specific therapeutic barrier was addressed?
According to Tech Times, the technique breaks the supply barrier for macrophage therapy.
How are the cells being produced?
The cells are produced via progenitor cells that self-renew in a lab.
Coverage (5)
- A new technique could keep cancer-fighting cells coming Tech Explorist · 4h ago
- Progenitor Cells Self-Renew in Lab, Breaking Macrophage Therapy Supply Barrier Tech Times · 4h ago
- Scientists at USC have figured out how to create an army of cells to fight cancer ThePrint · 4h ago
- USC scientists just unlocked an endless supply of cancer-fighting immune cells ScienceDaily · 4h ago
- Scientists Just Unlocked an Endless Army of Cancer-Fighting Cells ScienceAlert · 4h ago
Topics
Related trends
Another B vitamin linked to worse outcomes for cancer - Jacksonville Journal-Courier
Recent studies link Vitamin B12 deficiency to cancer outcomes and everyday fatigue.
This disease is more expensive than cancer and heart disease combined. And it’s only going to get worse.
The financial burden of dementia in the US is skyrocketing, outpacing even cancer and heart disease combined.
Grand Rapids oncologist says experimental pancreatic cancer drug showing promise in trials offers hope
An experimental drug for pancreatic cancer is generating hope among medical professionals and patients.